 although it was
greater in the latter two groups; patient satisfaction at
twelve weeks was not different between the groups.
Compared with above-knee EVLA, concomitant belowknee ablation (laser or sclerotherapy) resulted in fewer
varicosities and superior symptom relief at 6 weeks
(Table XIII).152 In another study the same authors treated
69 limbs with above-knee EVLA, 40 with C2 disease.15